Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy for Parkinson's disease].

V Fraix1

  • 1Inserm U318, université Joseph-Fourier, Grenoble, France. valerie.fraix@ujf-grenoble.fr

La Revue De Medecine Interne
|June 29, 2004
PubMed
Summary

Gene therapy offers new hope for Parkinson's disease (PD) by aiming to restore dopamine levels and protect neurons. Future strategies focus on neuroprotection and pathway restoration for improved treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of apathy in early Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD.

NPJ Parkinson's disease·2020
Same author

Battery longevity of neurostimulators in Parkinson disease: A historic cohort study.

Brain stimulation·2019
Same author

Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial.

Journal of neurology, neurosurgery, and psychiatry·2014
Same author

Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013.

Clinical EEG and neuroscience·2013
Same author

Major eosinophilia induced by subcutaneous apomorphine infusion: four cases.

European journal of neurology·2013

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Context:

  • Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons.
  • Current treatments like levodopa can cause motor fluctuations and dyskinesia.
  • Alternative therapies such as deep brain stimulation and gene therapy are being explored.

Purpose:

  • To review current gene therapy strategies for Parkinson's disease.
  • To highlight the potential of neuroprotection and restoration of the nigrostriatal pathway.
  • To identify future directions for genetic treatment of PD.

Summary:

  • Gene therapy for PD focuses on replacing dopamine synthesis enzymes or adding neurotrophic factors.
  • These approaches aim to protect and restore dopaminergic neurons in the nigrostriatal pathway.
  • Future strategies may incorporate genes to prevent apoptosis and detoxify free radicals.

Impact:

  • Gene therapy holds promise for developing more effective and potentially curative treatments for Parkinson's disease.
  • Restoring dopaminergic neuron function could alleviate motor symptoms and reduce treatment complications.
  • Advancements in gene therapy could significantly improve the quality of life for Parkinson's patients.

Related Experiment Videos